Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04666077 · ClinicalTrials.gov registry record · NA

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

A NA study of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT04666077: Completed NA study of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Icahn School of Medicine at Mount Sinai.

NCT04666077 is a NA study of Mild Cognitive Impairment and Alzheimers Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04666077, a NA study of Mild Cognitive Impairment and Alzheimers Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

Primary Outcome

Mini Mental Status Exam to assess cognition, behavior and function. Full score from 0-30, higher score indicates poorer health outcomes.

Interventions

  • BEHAVIORAL Home-based MT through Supervised, Supported Singing (H3S)
  • BEHAVIORAL Individualized Music Therapy (IMT)
  • OTHER Attention Control (AtCon)

Study Locations (2)

New York

  • Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel - New York
  • Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-08-27
Est. Completion 2025-07-25
Phase NA

What the finished NCT04666077 record still lists

NCT04666077 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which Home-based MT through Supervised, Supported Singing (H3S) is the first listed.

NCT04666077 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04666077 about?

NCT04666077 is a clinical study titled "Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)". This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control)...

What is the current status of trial NCT04666077?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-08-27. Estimated completion is 2025-07-25.

What conditions does trial NCT04666077 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Alzheimers Disease.

What interventions are being tested in trial NCT04666077?

The interventions under investigation include: Home-based MT through Supervised, Supported Singing (H3S) (BEHAVIORAL), Individualized Music Therapy (IMT) (BEHAVIORAL), Attention Control (AtCon) (OTHER).

Who is sponsoring clinical trial NCT04666077?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04666077 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04666077's enrollment target sits among peer trials

100 90th of 205 higher than 114 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04666077, the US trial registry maintained by the National Library of Medicine. NCT04666077 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.